Coya Therapeutics (COYA) Operating Income Growth (1y) (2023 - 2026)
Coya Therapeutics (COYA) Operating Income Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn | 1,386.07% |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - | 0.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.48% |
| Dec 31, 2025 | -47.81% |
| Sep 30, 2025 | 45.33% |
| Jun 30, 2025 | -98.22% |
| Mar 31, 2025 | -40.01% |
| Dec 31, 2024 | -324.79% |
| Sep 30, 2024 | -24.87% |
| Jun 30, 2024 | 0.56% |
| Mar 31, 2024 | -89.06% |
| Dec 31, 2023 | 190.60% |
| Sep 30, 2023 | -33.89% |
| Jun 30, 2023 | 5.57% |
| Mar 31, 2023 | -70.56% |